
VIR
Vir Biotechnology Inc.
Latest News for VIR
An update from Medivir AB ( ($SE:MVIR) ) is now available. Medivir AB has called its annual general meeting for 7 May 2026 in Stockholm, offering s......
In a report released yesterday, Alexander Blostein from Goldman Sachs maintained a Hold rating on Virtu Financial, with a price target of $46.00. A......
In a report released yesterday, Alexander Blostein from Goldman Sachs maintained a Hold rating on Virtu Financial, with a price target of $46.00. A......
Medivir AB ( ($SE:MVIR) ) has shared an announcement. Medivir is sharpening its focus on two proprietary programs aimed at serious conditions lacki......
Vidrala ( ($ES:VID) ) has provided an announcement. Vidrala has decided to increase the size of its existing share buyback programme to cover up to......
Kepler Capital analyst Inigo Egusquiza maintained a Buy rating on Vidrala on March 23 and set a price target of €100.50. The company’s shares close......
In a report released on March 18, Kevin Roger from Kepler Capital maintained a Buy rating on Viridien, with a price target of €180.00. The company’......
In a report released on March 18, Christophe dombu from Kepler Capital maintained a Buy rating on Virbac SA, with a price target of €415.00. The co......
Citi analyst Ephrem Ravi maintained a Hold rating on Vidrala today and set a price target of €85.00. According to TipRanks, Ravi is a 5-star analys......
Virco Manufacturing ( ($VIRC) ) has provided an update. On March 5, 2026, Virco Mfg. Corporation’s board declared a cash dividend of $0.025 per sha......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 10 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $9.61 | +4.8% | 1.75M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |